Legato Capital Management LLC Sells 25,537 Shares of Arteris, Inc. (NASDAQ:AIP)

Legato Capital Management LLC trimmed its holdings in shares of Arteris, Inc. (NASDAQ:AIPFree Report) by 23.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 85,683 shares of the company’s stock after selling 25,537 shares during the period. Legato Capital Management LLC owned approximately 0.21% of Arteris worth $873,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. The Manufacturers Life Insurance Company acquired a new position in shares of Arteris during the second quarter worth approximately $86,000. US Bancorp DE acquired a new position in shares of Arteris during the third quarter worth approximately $34,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of Arteris during the third quarter worth approximately $226,000. MetLife Investment Management LLC raised its position in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after purchasing an additional 9,551 shares during the period. Finally, Jacobs Levy Equity Management Inc. raised its position in shares of Arteris by 36.3% during the third quarter. Jacobs Levy Equity Management Inc. now owns 253,211 shares of the company’s stock worth $1,955,000 after purchasing an additional 67,414 shares during the period. 64.36% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 target price on shares of Arteris in a research report on Wednesday, November 6th.

View Our Latest Report on Arteris

Arteris Trading Up 2.3 %

NASDAQ AIP opened at $9.68 on Friday. The firm has a market capitalization of $388.91 million, a P/E ratio of -10.08 and a beta of 1.18. The business has a fifty day simple moving average of $10.49 and a 200 day simple moving average of $8.63. Arteris, Inc. has a 12 month low of $5.76 and a 12 month high of $12.64. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30.

Insider Activity at Arteris

In related news, Director Wayne C. Cantwell sold 5,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $11.01, for a total value of $55,050.00. Following the completion of the sale, the director now directly owns 233,198 shares of the company’s stock, valued at approximately $2,567,509.98. This represents a 2.10 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Paul L. Alpern sold 3,326 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $12.35, for a total value of $41,076.10. Following the completion of the sale, the vice president now directly owns 61,604 shares of the company’s stock, valued at $760,809.40. The trade was a 5.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 367,157 shares of company stock valued at $3,828,388. 33.70% of the stock is owned by insiders.

Arteris Company Profile

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIPFree Report).

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.